Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1766827016 | Bortezomib (product) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 1778391012 | Bortezomib | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3523552019 | Product containing bortezomib (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3523553012 | Product containing bortezomib | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3666902014 | Bortezomib product | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3713573016 | Bortezomib-containing product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 107815901000001115 | Bortezomib | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing bortezomib | Is a | Medicinal product acting as antineoplastic agent (product) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing bortezomib | Has active ingredient | Bortezomib | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing bortezomib | Is a | Product containing proteasome inhibitor | true | Inferred relationship | Existential restriction modifier | ||
| Product containing bortezomib | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing bortezomib | Is a | Virtual therapeutic moiety | false | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets